• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Mark Cuban’s Cost Plus Drug Company Sparks Moves To Change How Rx Drugs Are Priced

cafead

Administrator
Staff member
  • cafead   Jan 02, 2024 at 10:12: AM
via Mark Cuban's CPD offers a transparent way for patients to obtain affordable drugs. This has sparked changes in the ways in which traditional PBMs price and reimburse.

article source